SHZ · Financial Statements

Jiangsu Nhwa Pharmaceutical Co., LTD (002262.SZ) Financial Statements

$21.81 SHZ: 002262.SZ Market Cap $23.02B

Full income statement, balance sheet, and cash flow statement for Jiangsu Nhwa Pharmaceutical Co., LTD (002262.SZ), plus valuation and return ratios.

Annual financials are not yet available for this stock.

Valuation & Return Ratios

MetricValue
PEG Ratio2.51
EV / EBITDA14.50
FCF Yield—
Quick Ratio5.27
Interest Coverage—
Return 1Y-10.65%
Return 3Y-13.41%
Return 5Y57.69%

Jiangsu Nhwa Pharmaceutical Co., LTD (002262.SZ) financials — frequently asked questions

What is 002262.SZ EV/EBITDA?

Jiangsu Nhwa Pharmaceutical Co., LTD's enterprise value to EBITDA (EV/EBITDA) ratio is 14.50.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
002262.SZ Overview 002262.SZ Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.